StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.58−0.03 (-5.26%)

Close on Nov 18, 2026Market cap $3.25MP/E –Yield –

Imunon operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Imunon's operating income for the twelve months ending Mar 31, 2026 was -$14.81M. For fiscal 2025 it was -$14.65M. The highest annual figure on record is -$14.65M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.65M–
FY2024Dec 31, 2024-$19.13M–
FY2023Dec 31, 2023-$21.03M–
FY2022Dec 31, 2022-$24.92M–
FY2021Dec 31, 2021-$21.01M–
FY2020Dec 31, 2020-$18.49M–
FY2019Dec 31, 2019-$20.57M–
FY2018Dec 31, 2018-$21.07M–
FY2017Dec 31, 2017-$18.47M–
FY2016Dec 31, 2016-$20.65M–
FY2015Dec 31, 2015-$20.85M–
FY2014Dec 31, 2014-$24.72M–
FY2013Dec 31, 2013-$15.41M–
FY2012Dec 31, 2012-$22.14M–
FY2011Dec 31, 2011-$23.02M–
FY2010Dec 31, 2010-$19.64M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026-$4.31M–
Q4 FY2025Dec 31, 2025-$4.26M–
Q3 FY2025Sep 30, 2025-$3.48M–
Q2 FY2025Jun 30, 2025-$2.77M–
Q1 FY2025Mar 31, 2025-$4.15M–
Q4 FY2024Dec 31, 2024-$4.15M–
Q3 FY2024Sep 30, 2024-$4.96M–
Q2 FY2024Jun 30, 2024-$5.01M–
Q1 FY2024Mar 31, 2024-$5.01M–
Q4 FY2023Dec 31, 2023-$5.97M–
Q3 FY2023Sep 30, 2023-$3.90M–
Q4 FY2022Dec 31, 2022-$6.93M–
Q3 FY2022Sep 30, 2022-$6.17M–
Q2 FY2022Jun 30, 2022-$5.98M–
Q1 FY2022Mar 31, 2022-$5.84M–
Q4 FY2021Dec 31, 2021-$5.49M–
Q3 FY2021Sep 30, 2021-$5.06M–
Q2 FY2021Jun 30, 2021-$5.07M–
Q1 FY2021Mar 31, 2021-$5.38M–
Q4 FY2020Dec 31, 2020-$4.79M–
Q3 FY2020Sep 30, 2020-$4.16M–
Q2 FY2020Jun 30, 2020-$4.77M–
Q1 FY2020Mar 31, 2020-$4.77M–
Q4 FY2019Dec 31, 2019-$4.75M–
Q3 FY2019Sep 30, 2019-$5.39M–
Q2 FY2019Jun 30, 2019-$5.57M–
Q1 FY2019Mar 31, 2019-$4.86M–
Q4 FY2018Dec 31, 2018-$4.75M–
Q3 FY2018Sep 30, 2018-$4.02M–
Q2 FY2018Jun 30, 2018-$8.01M–
Q1 FY2018Mar 31, 2018-$4.28M–
Q4 FY2017Dec 31, 2017-$4.68M–
Q3 FY2017Sep 30, 2017-$4.40M–
Q2 FY2017Jun 30, 2017-$4.40M–
Q1 FY2017Mar 31, 2017-$4.82M–
Q4 FY2016Dec 31, 2016-$5.13M–
Q3 FY2016Sep 30, 2016-$5.60M–
Q2 FY2016Jun 30, 2016-$4.74M–
Q1 FY2016Mar 31, 2016-$5.18M–

More Imunon figures

See a number that looks wrong?